Essa opção é uma maneira eficaz de proporcionar aos seus pacientes melhores resultados no controle do diabetes.
Entre em contato conosco
1. Lauritzen T, Pramming S., Deckert T., Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia. 1983;24(5):326-329.
2. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemias with long-term continuous subcutaneous insulin infusion in type-1 diabetes. Diabetes Care.1996;19:324-327.
3. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in type-1 diabetes patients using insulin pump therapy. Diabetes Research and Clinical Practice 2005; 69: 14-25.
4. Doyle EA, Weinzimer, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV. A randomized prospective trial comparing the efficacy of insulin pump therapy with multiple daily injections using insulin glargine. Diabetes Care. 2004;27(7):1554-1558.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
6. Pickup JC. Insulin-Pump Therapy for Type 1 Diabetes Mellitus. N Engl J Med. 2012.
7. DeVries JH, Snoek FJ, Kostense PJ, Mausrel N, Heinee RJ. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type-1 diabetes for patients with long-standing poor glycemic control. Diabetes Care. 2002 Nov;25(11):2074-80.